Ranbaxy Laboratories Limited is among the top ten generic pharmaceutical companies and ’s largest pharmaceutical company. Recently, the company announced its acquisition of the unbranded generic business of Allen S.p.A. (a division of GlaxoSmithKline (GSK) Italy
Malvinder Mohan Singh, CEO and MD, Ranbaxy Laboratories Ltd., said, "This acquisition of the Allen Generic business from GSK will fast track Ranbaxy’s growth plans in
. This product portfolio complements Ranbaxy's own pipeline of products for the Italian market and will enable the Company to utilise opportunities arising from future patent expiries."
The India-bases Ranbaxy Laboratories Limited is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients worldwide.
Read the complete press release.
Comment Preview